Trials / Completed
CompletedNCT02348476
A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective chart review to assess the tolerability and efficacy of treatment with Simbrinza™ used for patients with Open-Angle Glaucoma or Ocular Hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No study drug is administered in this study. |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2015-01-28
- Last updated
- 2015-09-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02348476. Inclusion in this directory is not an endorsement.